Overview
NUS market data
Price History
NUS price chart
Valuation & Profitability
- P/E (TTM)
- 4.30 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.18 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 4.9% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 3.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.49 – $14.62 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $234.4M · P/B 0.58 · P/S 0.16.
Company News
Nu Skin Enterprises shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 guidance below estimates. Also, the company cut its FY26 sales guidance below estimates.Benzinga · Aug 11, 2026, 1:22 PM
Nu Skin Enterprises Sees FY2026 GAAP EPS $(4.90)-$(4.73)Benzinga · Aug 10, 2026, 8:14 PM
Nu Skin Enterprises Sees Q3 GAAP EPS $0.00-$0.09Benzinga · Aug 10, 2026, 8:14 PM
Nu Skin Enterprises Sees FY2026 Adj EPS $0.70-$0.90 vs $1.00 Est; Lowers FY2026 Sales Guidance from $1.350B-$1.500B to $1.280B-$1.350B vs $1.425B EstBenzinga · Aug 10, 2026, 8:13 PM
Nu Skin Enterprises Sees Q3 Adj EPS $0.10-$0.20 vs $0.32 Est; Sees Sales $310.000M-$340.000M vs $375.500M EstBenzinga · Aug 10, 2026, 8:13 PM
Nu Skin Enterprises Q2 Adj. EPS $0.20, Inline, Sales $320.112M Miss $345.200M EstimateBenzinga · Aug 10, 2026, 8:09 PM
Nu Skin Enterprises Stockholders Approve Amended And Restated 2024 Omnibus Incentive Plan; Amended Plan Increases Share Authorization By 2.85M Shares; Plan Termination Date Extended To May 28, 2036Benzinga · May 29, 2026, 8:15 PM
8-K filing — NU SKIN ENTERPRISES, INC. (NUS)SEC EDGAR · May 29, 2026, 8:05 PM